Literature DB >> 20739499

Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits.

A Faruq1, L Dadson, H Cox, F Alcock, A R Parker.   

Abstract

The technical and diagnostic performances of five commercially available enzyme-linked immunosorbent assays for the measurement of anti-diphtheria toxoid IgG antibodies were evaluated. There was good agreement between the relative sensitivities of the five assays, but the relative specificity of one of the assays differed from that of the other four assays. Three of the five assays possessed recoveries of the international reference material NIBSC 00/496 within the range of 90% to 110% at antibody levels >0.1 IU/ml. The data suggest that there are manufacture-dependent differences in relative sensitivity, specificity, and accuracy for the determination of anti-diphtheria toxoid IgG antibodies that could result in different diagnostic interpretations.

Mesh:

Substances:

Year:  2010        PMID: 20739499      PMCID: PMC2952985          DOI: 10.1128/CVI.00077-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

1.  Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test.

Authors:  M Melville-Smith; A Balfour
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

2.  Studies on the correlation of a range of immunoassays for diphtheria antitoxin with the guinea-pig intradermal test.

Authors:  P A Knight; J Tilleray; J Queminet
Journal:  Dev Biol Stand       Date:  1986

Review 3.  Diphtheria and tetanus toxoids.

Authors:  J W Smith
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

4.  Immunity to diphtheria in a sample of adult population from central Italy.

Authors:  C Cellesi; A Zanchi; C Michelangeli; F Giovannoni; A Sansoni; G M Rossolini
Journal:  Vaccine       Date:  1989-10       Impact factor: 3.641

5.  Association of diphtheria toxin with Vero cells. Demonstration of a receptor.

Authors:  J L Middlebrook; R B Dorland; S H Leppla
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

6.  The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Authors:  W J Edmunds; R G Pebody; H Aggerback; S Baron; G Berbers; M A Conyn-van Spaendonck; H O Hallander; R Olander; P A Maple; H E Melker; P Olin; F Fievret-Groyne; C Rota; S Salmaso; A Tischer; C von-Hunolstein; E Miller
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

7.  Comparison of four serological methods for the detection of diphtheria anti-toxin antibody.

Authors:  J Walory; P Grzesiowski; W Hryniewicz
Journal:  J Immunol Methods       Date:  2000-11-01       Impact factor: 2.303

8.  Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Authors:  T Nordøy; A Husebekk; I S Aaberge; P A Jenum; H H Samdal; L B Flugsrud; A C Kristoffersen; H Holte; S Kvaløy; A Kolstad
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

9.  Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women.

Authors:  Tatiana C S Bonetti; Regina C M Succi; Lily Y Weckx; L Tavares-Lopes; M Isabel de Moraes-Pinto
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

10.  Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.

Authors:  Michael J Robinson; Carrie Heal; Elizabeth Gardener; Peter Powell; Douglas G Sims
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

View more
  1 in total

1.  Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies.

Authors:  A A Zasada; W Rastawicki; K Śmietańska; N Rokosz; M Jagielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-26       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.